The#1annuallyupdatedgeneralmedicaltext--presentsthemostimportantdiagnosticandtreatmentrecommendationsaswellasthemostusefulnewclinicaldevelopmentsineveryfieldofadultmedicine.Formorethansixdecades,CURRENTMedicalDiagnosis&Treatmenthasbeendeliveringtheauthoritativeinformationstudents,residents,andcliniciansneedtobuildtheirmedicalknowledge,expertise,andconfidence.Writtenbytopexpertsintheirfields,thisunmatchedguideisformattedinawaythatenablesreaderstofindtheanswerstheyneedquicklyandeasily.CURRENTMedicalDiagnosis&Treatment2024reflectsthelatestdevelopmentsinmedicine,guidelines,references,andmore.You’llfindauthoritative,evidence-basedcoverageofmorethan1,000diseasesanddisordersalongwithaconcise,yetthoroughsynopsisofdiagnosisandtreatment.Thistrustedclassiccoversallaspectsofoutpatientandinpatientcareandincludesdiscussionofnewdevelopmentsandbreakthroughsinmedicine.CURRENTMedicalDiagnosis&Treatment2024features:Acomprehensiveapproachtopatientcare,focusingonthediagnostictoolsrelevanttodailypracticeCoverageofmorethan1,000diseasesanddisordersHundredsofdrugtreatmenttablesforquickaccesstoindexedtradenamesAnnualupdatestotopicsinallchaptersinaconsistentformat,drugs,tables,andimagesYearinReviewhighlightingthemanytopicswithsignificantclinicalchangesoverthelastyearEssentialsofDiagnosisformostdiseases/disordersDiagnosticandtreatmentalgorithmspresentcomplexinformationinanat-a-glancestyleHundredsoffull-colorphotosandillustrationsNewtothisedition:LatestUSPSFTrecommendationsforcardiovascularriskpreventionSignificantnewopioidprescribingguidelinesfromtheCDCClarificationonthedistinctionbetweenuncontrolledhypertensiveandhypertensionemergencyLatestclassificationoflymphomasreleasedbytheWHORecommendationsfortheinitiationandtitrationoftreatmentforchronichypertensioninpregnancyCurrenttreatmentguidelinesandmedicationsforHpyloriinfectionClassificationoftherole,dosing,andpotentialrisksofJAKinhibitorsandanti-23antibody(Risankizumab)inthetreatmentofIBDUpdatesthatunderscorethegrowingutilityofcombinationtreatmentsforhighLDLlevels,especiallyamonghighandveryhigh-riskpatientsTheWHOrevisionofthepathologicalclassificationofrenalcellcarcinomatoassistwithprognosispredictionandtreatmentdecisions
